Drugs / ALN-PCS02
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01437059 Comparator | Sep 2011 → Mar 2012 | low density lipoprotein cholesterol, mild elevation of | Alnylam Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALN-PCS02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01437059 ↗ |